These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34111424)

  • 1. C2C12 myoblasts are more sensitive to the toxic effects of simvastatin than myotubes and show impaired proliferation and myotube formation.
    Sanvee GM; Bouitbir J; Krähenbühl S
    Biochem Pharmacol; 2021 Aug; 190():114649. PubMed ID: 34111424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of insulin resistance by simvastatin in C2C12 myotubes and in mouse skeletal muscle.
    Sanvee GM; Panajatovic MV; Bouitbir J; Krähenbühl S
    Biochem Pharmacol; 2019 Jun; 164():23-33. PubMed ID: 30796916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility to simvastatin-induced toxicity is partly determined by mitochondrial respiration and phosphorylation state of Akt.
    Mullen PJ; Zahno A; Lindinger P; Maseneni S; Felser A; Krähenbühl S; Brecht K
    Biochim Biophys Acta; 2011 Dec; 1813(12):2079-87. PubMed ID: 21839782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-1 prevents simvastatin-induced myotoxicity in C2C12 myotubes.
    Bonifacio A; Sanvee GM; Brecht K; Kratschmar DV; Odermatt A; Bouitbir J; Krähenbühl S
    Arch Toxicol; 2017 May; 91(5):2223-2234. PubMed ID: 27734117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTORC2 is an important target for simvastatin-associated toxicity in C2C12 cells and mouse skeletal muscle - Roles of Rap1 geranylgeranylation and mitochondrial dysfunction.
    Sanvee GM; Hitzfeld L; Bouitbir J; Krähenbühl S
    Biochem Pharmacol; 2021 Oct; 192():114750. PubMed ID: 34461118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes.
    Kwak HB; Thalacker-Mercer A; Anderson EJ; Lin CT; Kane DA; Lee NS; Cortright RN; Bamman MM; Neufer PD
    Free Radic Biol Med; 2012 Jan; 52(1):198-207. PubMed ID: 22080086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin prevents and reverts simvastatin-induced toxicity in C2C12 skeletal muscle cells.
    Sanvee GM; Bouitbir J; Krähenbühl S
    Sci Rep; 2019 May; 9(1):7409. PubMed ID: 31092879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-hydroxy 3-methylglutaryl coenzyme A reductase inhibition impairs muscle regeneration.
    Trapani L; Segatto M; La Rosa P; Fanelli F; Moreno S; Marino M; Pallottini V
    J Cell Biochem; 2012 Jun; 113(6):2057-63. PubMed ID: 22274883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinsulin C-Peptide Enhances Cell Survival and Protects against Simvastatin-Induced Myotoxicity in L6 Rat Myoblasts.
    Essid SM; Bevington A; Brunskill NJ
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin suppresses the differentiation of C2C12 myoblast cells via a Rac pathway.
    Baba TT; Nemoto TK; Miyazaki T; Oida S
    J Muscle Res Cell Motil; 2008; 29(2-5):127-34. PubMed ID: 18792797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AKT/mTOR signaling pathway plays a key role in statin-induced myotoxicity.
    Bonifacio A; Sanvee GM; Bouitbir J; Krähenbühl S
    Biochim Biophys Acta; 2015 Aug; 1853(8):1841-9. PubMed ID: 25913013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 1,25(OH)2 D3 and 25(OH)D3 on C2C12 Myoblast Proliferation, Differentiation, and Myotube Hypertrophy.
    van der Meijden K; Bravenboer N; Dirks NF; Heijboer AC; den Heijer M; de Wit GM; Offringa C; Lips P; Jaspers RT
    J Cell Physiol; 2016 Nov; 231(11):2517-28. PubMed ID: 27018098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactoferrin promotes murine C2C12 myoblast proliferation and differentiation and myotube hypertrophy.
    Kitakaze T; Oshimo M; Kobayashi Y; Ryu M; Suzuki YA; Inui H; Harada N; Yamaji R
    Mol Med Rep; 2018 Apr; 17(4):5912-5920. PubMed ID: 29436684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simvastatin inhibits glucose metabolism and legumain activity in human myotubes.
    Smith R; Solberg R; Jacobsen LL; Voreland AL; Rustan AC; Thoresen GH; Johansen HT
    PLoS One; 2014; 9(1):e85721. PubMed ID: 24416446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coenzyme Q nanodisks counteract the effect of statins on C2C12 myotubes.
    Moschetti A; Dagda RK; Ryan RO
    Nanomedicine; 2021 Oct; 37():102439. PubMed ID: 34256063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin inhibits glucose uptake activity and GLUT4 translocation through suppression of the IR/IRS-1/Akt signaling in C2C12 myotubes.
    Li W; Liang X; Zeng Z; Yu K; Zhan S; Su Q; Yan Y; Mansai H; Qiao W; Yang Q; Qi Z; Huang Z
    Biomed Pharmacother; 2016 Oct; 83():194-200. PubMed ID: 27470565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of type IV collagen on myogenic characteristics of IGF-I gene-engineered myoblasts.
    Ito A; Yamamoto M; Ikeda K; Sato M; Kawabe Y; Kamihira M
    J Biosci Bioeng; 2015 May; 119(5):596-603. PubMed ID: 25454061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of simvastatin on cholesterol metabolism in C2C12 myotubes and HepG2 cells, and consequences for statin-induced myopathy.
    Mullen PJ; Lüscher B; Scharnagl H; Krähenbühl S; Brecht K
    Biochem Pharmacol; 2010 Apr; 79(8):1200-9. PubMed ID: 20018177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK1/2 inhibition promotes robust myotube growth via CaMKII activation resulting in myoblast-to-myotube fusion.
    Eigler T; Zarfati G; Amzallag E; Sinha S; Segev N; Zabary Y; Zaritsky A; Shakked A; Umansky KB; Schejter ED; Millay DP; Tzahor E; Avinoam O
    Dev Cell; 2021 Dec; 56(24):3349-3363.e6. PubMed ID: 34932950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel in vitro model for the assessment of postnatal myonuclear accretion.
    Kneppers A; Verdijk L; de Theije C; Corten M; Gielen E; van Loon L; Schols A; Langen R
    Skelet Muscle; 2018 Feb; 8(1):4. PubMed ID: 29444710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.